The study has also described the interaction between IGFBP3 and miR-34a, a microRNA-like molecule that plays a crucial role ...
The medicine begins the production of two tumour-inhibiting microRNA molecules known as miR-34a and miR-34b/c. It also binds to and activates other enzymes which help regulate cellular metabolism.